How has Eton Pharmaceuticals, Inc.'s other non-current liabilities changed year-over-year?

Eton Pharmaceuticals, Inc.'s other non-current liabilities decreased by 14.8% year-over-year, from $4.15M to $3.54M.

What does other non-current liabilities mean?

Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.

Eton Pharmaceuticals, Inc. ETON Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Zevra Therapeutics, Inc.ZVRA

$1.86M-61.9%

XER

Xeris Biopharma Holdings, Inc.XERS

$8.13M+68.1%

Ultragenyx PharmaceuticalRARE

$42M+145%

ANI PharmaceuticalsANIP

$16.45M+134%

Crinetics PharmaceuticalsCRNX

$4.93M+179%

Catalyst PharmaceuticalCPRX

$280K+8.1%

Segments

By product

See full

Increlex$1.76M—

Other financials

Income statement

See full

Revenue$24.3M+40.4%

Gross profit$14.7M+49.4%

Operating income$2.4M+614%

Net income$1.6M+199%

EPS (diluted)$0.05+183%

Balance sheet

See full

Cash & equivalents$19.7M+12.9%

Total debt$31.3M+3.7%

Total equity$30.6M+25.2%

Total assets$97.7M+16.3%

Cash flow

See full

Operating cash flow$7.4M+254%

CapEx$75.0K—

Free cash flow$7.3M+251%

Valuation

See full

Market cap$930.79M+156%

Enterprise value$942.39M+150%

P/S10.7×+3.2×

Profitability

See full

Gross margin54.8%-3.7pp

Operating margin-15.1%—

Net margin-9.5%-2.7pp

FCF margin17.1%—

Returns & leverage

See full

Return on equity-34.2%+0.9pp

Debt / equity1×-0.2×

Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s other non-current liabilities?: Eton Pharmaceuticals, Inc. (ETON) reported other non-current liabilities of $3.54M in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s other non-current liabilities changed year-over-year?: Eton Pharmaceuticals, Inc.'s other non-current liabilities decreased by 14.8% year-over-year, from $4.15M to $3.54M.
What does other non-current liabilities mean?: Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.